1887

Microbial Genomics logo

Volume 9, Issue 7

Emergence of linezolid-resistant in a tertiary hospital in Copenhagen Open Access

Abstract

Linezolid is used as first-line treatment of infections caused by vancomycin-resistant . However, resistance to linezolid is increasingly detected. The aim of the present study was to elucidate the causes and mechanisms for the increase in linezolid-resistant at Copenhagen University Hospital – Rigshospitalet. We therefore combined patient information on linezolid treatment with whole-genome sequencing data for vancomycin- or linezolid-resistant isolates that had been systematically collected since 2014 (=458). Whole-genome sequencing was performed for multilocus sequence typing (MLST), identification of linezolid resistance-conferring genes/mutations and determination of phylogenetically closely related strains. The collection of isolates belonged to prevalent vancomycin-resistant MLST types. Among these, we identified clusters of closely related linezolid-resistant strains compatible with nosocomial transmission. We also identified linezolid-resistant enterococcus isolates not genetically closely related to other isolates compatible with generation of linezolid resistance. Patients with the latter isolates were significantly more frequently exposed to linezolid treatment than patients with related linezolid-resistant enterococcus isolates. We also identified six patients who initially carried a vancomycin-resistant, linezolid-sensitive enterococcus, but from whom vancomycin-resistant, linezolid-resistant enterococci (LVRE) closely related to their initial isolate were recovered after linezolid treatment. Our data illustrate that linezolid resistance may develop in the individual patient subsequent to linezolid exposure and can be transmitted between patients in a hospital setting.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): outbreak , oxazolidinone , resistance mutation , selection pressure , SNP , VRE and whole-genome sequencing
Funding
This study was supported by the:
  • Novo Nordisk Fonden (Award NNF16OC0023482)
    • Principle Award Recipient: SusanneHäussler
© 2023 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001055
2023-07-06
2024-04-28
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/7/mgen001055.html?itemId=/content/journal/mgen/10.1099/mgen.0.001055&mimeType=html&fmt=ahah

References

  1. Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 2012; 3:421–433 [View Article] [PubMed]
     [Google Scholar]
  2. ECDC The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. n.d
  3. Pinholt M, Mollerup S, Boye K, Worning P, Holzknecht BJ et al. Investigation of the introduction and dissemination of vanB Enterococcus faecium in the Capital Region of Denmark and development of a rapid and accurate clone-specific vanB E. faecium PCR. J Antimicrob Chemother 2021; 76:2260–2267 [View Article] [PubMed]
     [Google Scholar]
  4. Gisselø KL, Rubin IMC, Knudsen MS, From-Hansen M, Stangerup M et al. Substantial decrease in vancomycin-resistant Enterococcus faecium outbreak duration and number of patients during the danish COVID-19 lockdown: a prospective observational study. Microb Drug Resist 2022; 28:73–80 [View Article] [PubMed]
     [Google Scholar]
  5. Hammerum AM, Justesen US, Pinholt M, Roer L, Kaya H et al. Surveillance of vancomycin-resistant enterococci reveals shift in dominating clones and national spread of a vancomycin-variable vanA Enterococcus faecium ST1421-CT1134 clone, Denmark, 2015 to March 2019. Euro Surveill 2019; 24:1900503 [View Article] [PubMed]
     [Google Scholar]
  6. Pinholt M, Bayliss SC, Gumpert H, Worning P, Jensen VVS et al. WGS of 1058 Enterococcus faecium from Copenhagen, Denmark, reveals rapid clonal expansion of vancomycin-resistant clone ST80 combined with widespread dissemination of a vanA-containing plasmid and acquisition of a heterogeneous accessory genome. J Antimicrob Chemother 2019; 74:1776–1785 [View Article] [PubMed]
     [Google Scholar]
  7. Henius AE, Cavaco LM. Danmap; 2019
  8. Hertz FB, Nielsen KL, Olsen MH, Ebdrup SR, Nielsen C et al. Vancomycin-resistant Enterococcus faecium: should we screen on admission?. APMIS 2022; 130:657–660 [View Article] [PubMed]
     [Google Scholar]
  9. ECDC Surveillance of antimicrobial resistance in Europe. In European Centre for Disease Prevention and Control Stokholm; 2018
     [Google Scholar]
  10. Torres C, Alonso CA, Ruiz-Ripa L, León-Sampedro R, Del Campo R et al. Antimicrobial resistance in Enterococcus spp. of animal origin. Microbiol Spectr 2018; 6:6 [View Article] [PubMed]
     [Google Scholar]
  11. Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 2014; 12:1221–1236 [View Article] [PubMed]
     [Google Scholar]
  12. Ruiz-Ripa L, Feßler AT, Hanke D, Eichhorn I, Azcona-Gutiérrez JM et al. Mechanisms of linezolid resistance among Enterococci of clinical origin in Spain—detection of optrA- and cfr(D)-carrying E. faecalis. Microorganisms 2020; 8:1155 [View Article]
     [Google Scholar]
  13. Sharkey LKR, Edwards TA, O’Neill AJ, Wright GD. ABC-F proteins mediate antibiotic resistance through ribosomal protection. mBio 2016; 7: [View Article]
     [Google Scholar]
  14. Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005; 57:1064–1073 [View Article] [PubMed]
     [Google Scholar]
  15. Antonelli A, D’Andrea MM, Brenciani A, Galeotti CL, Morroni G et al. Characterization of poxtA, a novel phenicol–oxazolidinone–tetracycline resistance gene from an MRSA of clinical origin. J Antimicrob Chemother 2018; 73:1763–1769 [View Article]
     [Google Scholar]
  16. Dejoies L, Sassi M, Schutz S, Moreaux J, Zouari A et al. Genetic features of the poxtA linezolid resistance gene in human enterococci from France. J Antimicrob Chemother 2021; 76:1978–1985 [View Article] [PubMed]
     [Google Scholar]
  17. Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Drug Resist Updat 2018; 40:25–39 [View Article] [PubMed]
     [Google Scholar]
  18. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998; 42:3251–3255 [View Article] [PubMed]
     [Google Scholar]
  19. Xiong YQ, Yeaman MR, Bayer AS. Linezolid: a new antibiotic. Drugs Today 2000; 36:631–639 [View Article] [PubMed]
     [Google Scholar]
  20. Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H. Linezolid: a promising option in the treatment of Gram-positives. J Antimicrob Chemother 2017; 72:354–364 [View Article] [PubMed]
     [Google Scholar]
  21. Pfaller MA, Mendes RE, Streit JM, Hogan PA, Flamm RK. Five-year summary of In Vitro activity and resistance mechanisms of linezolid against clinically important Gram-Positive Cocci in the United States from the LEADER surveillance program (2011 to 2015). Antimicrob Agents Chemother 2017; 61: [View Article]
     [Google Scholar]
  22. Mendes RE, Hogan PA, Jones RN, Sader HS, Flamm RK. Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates. J Antimicrob Chemother 2016; 71:1860–1865 [View Article] [PubMed]
     [Google Scholar]
  23. Lazaris A, Coleman DC, Kearns AM, Pichon B, Kinnevey PM et al. Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE. J Antimicrob Chemother 2017; 72:3252–3257 [View Article] [PubMed]
     [Google Scholar]
  24. Youenou B, Martins Simoes P, Tristan A, Farfour E, Beauruelle C et al. Linezolid resistance: detection of the cfr(B) gene in French clinical MRSA strains. J Antimicrob Chemother 2023; 78:445–449 [View Article] [PubMed]
     [Google Scholar]
  25. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012; 67:2640–2644 [View Article] [PubMed]
     [Google Scholar]
  26. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol 2014; 15:524 [View Article] [PubMed]
     [Google Scholar]
  27. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30:1312–1313 [View Article]
     [Google Scholar]
  28. Didelot X, Wilson DJ. ClonalFrameML: efficient inference of recombination in whole bacterial genomes. PLoS Comput Biol 2015; 11:e1004041 [View Article] [PubMed]
     [Google Scholar]
  29. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021; 49:W293–W296 [View Article]
     [Google Scholar]
  30. Gabrielaite M, Misiakou M-A, Marvig RL. BacDist: Snakemake pipeline for bacterial SNP distance and phylogeny analysis. In BacDist: Snakemake Pipeline for Bacterial SNP Distance and Phylogeny Analysis [View Article]
     [Google Scholar]
  31. Penven M, Zouari A, Nogues S, Collet A, Lecourt M et al. Web-based prediction of antimicrobial resistance in enterococcal clinical isolates by whole-genome sequencing. Eur J Clin Microbiol Infect Dis 2023; 42:67–76 [View Article] [PubMed]
     [Google Scholar]
  32. Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin Infect Dis 2004; 39:1010–1015 [View Article] [PubMed]
     [Google Scholar]
  33. Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46:3334–3336 [View Article] [PubMed]
     [Google Scholar]
  34. Caballero-Granado FJ, Becerril B, Cisneros JM, Cuberos L, Moreno I et al. Case-control study of risk factors for the development of Enterococcal bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20:0083–0090 [View Article]
     [Google Scholar]
  35. Ruggero KA, Schroeder LK, Schreckenberger PC, Mankin AS, Quinn JP. Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs. Diagn Microbiol Infect Dis 2003; 47:511–513 [View Article] [PubMed]
     [Google Scholar]
  36. Olearo F, Both A, Belmar Campos C, Hilgarth H, Klupp E-M et al. Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption. Int J Med Microbiol 2021; 311:151477 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.001055
Loading
Emergence of linezolid-resistant Enterococcus faecium in a tertiary hospital in Copenhagen
M Gen 9, 001055 (2023); https://doi.org/10.1099/mgen.0.001055
/content/journal/mgen/10.1099/mgen.0.001055
/content/journal/mgen/10.1099/mgen.0.001055
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error